OTCMKTS:GNWSF - GeneNews Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0880 0.00 (0.00 %) (As of 05/22/2019 12:59 PM ET)Previous Close$0.0867Today's Range$0.0880 - $0.088052-Week Range$0.0130 - $0.1560Volume5,000 shsAverage Volume8,218 shsMarket Capitalization$15.69 millionP/E RatioN/ADividend YieldN/ABeta4.52 ProfileChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada. Receive GNWSF News and Ratings via Email Sign-up to receive the latest news and ratings for GNWSF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNWSF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.genenews.com/ Phone905-209-2030Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$410,000.00 Price / Sales38.26 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-2.93Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,940,000.00 Net Margins-2,524.26% Return on EquityN/A Return on Assets-151.10%Miscellaneous Employees16 Outstanding Shares178,260,000Market Cap$15.69 million Next Earnings Date5/22/2019 (Estimated) OptionableNot Optionable GeneNews (OTCMKTS:GNWSF) Frequently Asked Questions What is GeneNews' stock symbol? GeneNews trades on the OTCMKTS under the ticker symbol "GNWSF." When is GeneNews' next earnings date? GeneNews is scheduled to release their next quarterly earnings announcement on Wednesday, May 22nd 2019. View Earnings Estimates for GeneNews. Has GeneNews been receiving favorable news coverage? News articles about GNWSF stock have trended neutral recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. GeneNews earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. Who are some of GeneNews' key competitors? Some companies that are related to GeneNews include Trinity Biotech (TRIB), Celldex Therapeutics (CLDX), ImmuCell (ICCC), Achieve Life Sciences (ACHV), Akers Biosciences (AKER), Arca Biopharma (ABIO), BG Medicine (BGMD), Response Genetics (RGDXQ) and Fluoropharma Medical (FPMI). What other stocks do shareholders of GeneNews own? Based on aggregate information from My MarketBeat watchlists, some companies that other GeneNews investors own include Pure Energy Minerals (PE), OrganiGram (OGI), CytRx (CYTR), BBX Capital (BBXTB), Obsidian Energy (OBE), Canopy Growth (CGC), Athabasca Oil (ATH), NIKON CORP/ADR (NINOY), Oritani Financial (ORIT) and Newmark Group (NMRK). Who are GeneNews' key executives? GeneNews' management team includes the folowing people: Mr. James R. Howard-Tripp, Exec. Chairman & CEOMs. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDLProf. Choong-Chin Liew Ph.D., Co-FounderMr. Warren Whitehead, Chief Accountant (Age 67)Mr. David Suria, Sr. Scientist How do I buy shares of GeneNews? Shares of GNWSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is GeneNews' stock price today? One share of GNWSF stock can currently be purchased for approximately $0.0880. How big of a company is GeneNews? GeneNews has a market capitalization of $15.69 million and generates $410,000.00 in revenue each year. GeneNews employs 16 workers across the globe. What is GeneNews' official website? The official website for GeneNews is http://www.genenews.com/. How can I contact GeneNews? GeneNews' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at 905-209-2030 or via email at [email protected] MarketBeat Community Rating for GeneNews (OTCMKTS GNWSF)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 57 (Vote Outperform)Underperform Votes: 49 (Vote Underperform)Total Votes: 106MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe GNWSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNWSF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: Are all No-Load Funds Equal? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.